India, Nov. 19 -- The Government of India has issued a release:

Union Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, through a draft Gazette Notification G.S.R. 983 (E) dated 6th November, to include 'antimicrobials' in the definition of 'New Drug' under Rule 2(1)(w)(v).

Antimicrobial resistance (AMR) is a major global public health concern and a priority requiring coordinated action. The G20 New Delhi Leaders' Declaration also underscored the need to address antimicrobial resistance through a One Health approach.

The proposed amendment has been initiated in view of concerns regarding the grant of manufacturing licences for antimicrobial products without adequate regulato...